OraSure to Present at J.P Morgan Healthcare Conference

Recludix Pharma to Present at the Annual J.P. Morgan Healthcare Conference
Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D., president and chief executive officer of Recludix,
Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
43rd Annual J.P. Morgan Healthcare Conference – Company Presentation Date: Wednesday, January 15, 2025 Time: 3:45 p.m. - 4:25 p.m. PT Location: The Westin St. Francis Hotel, San Francisco, CA (Elizabethan B)
J.P. Morgan increases security for 2025 conference
The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health and pharmaceutical sectors.
Samsung, Celltrion to exhibit at J.P. Morgan Healthcare Conference
Korean biopharmaceutical firms Samsung Biologics, Celltrion, and Lotte Biologics will showcase their advancements at the J.P. Morgan Healthcare Conference.
ADARx Pharmaceuticals to Present at the J.P. Morgan 43ʳᵈ Annual Healthcare Conference
About ADARx Pharmaceuticals ADARx Pharmaceuticals, Inc. is a late-stage clinical biotechnology company dedicated to transforming cutting-edge science into next-generation RNA medicines across a wide range of therapeutic areas.
Celltrion to reveal four-year road map at J.P. Morgan Healthcare Conference
Celltrion will reveal its dual-track strategy to juggle the development of both biosimilars and original drugs at the J.P. Morgan Healthcare Conference.
AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Amgen (NASDAQ:AMGN) will present at the 2025 J.P. Morgan Healthcare Conference at 3:00 p.m. PT on Monday, January 13, 2025. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference.
OraSure to Present at the J.P Morgan Healthcare Conference
About OraSure Technologies, Inc. OraSure Technologies, Inc. (“OraSure”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access,
Alyea Therapeutics to Present at Biotech Showcase 2025 During 43rd Annual J.P. Morgan Healthcare Conference Week
LAS VEGAS, NV / ACCESSWIRE / / Alyea Therapeutics Corporation Inc. ("Alyea" or the "Company"), a subsidiary of Alt 5 Sigma Corporation (NASDAQ:ALTS), announced today its engagement in key events ...
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced ...
Nvidia In Focus: CES This Week, J.P. Morgan Healthcare Conference Next Week, February Earnings
Then, next week, Nvidia is on the road again at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, which ...